纳米技术在寄生虫学中的应用

doi:10.16431/j.cnki.1671-7236.2017.11.026

Abstract

Abstract:

Nanotechnology is the emerging development of the core information technology in the 1980s, and it has been widely used in life medicine, optoelectronics and other fields. Nanotechnology is effectively combined with parasitic disease reagents instrumentation, drug treatment, vaccine prevention and control, and has a comprehensive application in the nano-gold standard test strip test kit and equipment, nano-carrier targeted anthelmintic drugs, new nano-vaccine adjuvant of research and development, etc. It penetrates deeply into the medical field and is widely used in parasitology. With the starting point of the application of nanotechnology in parasitology, this paper focused on the pathogenic detection, anthelmintic drugs and vaccine adjuvants of parasitic diseases. The authors described the application of nano-technology, such as colloidal gold labeled immunoaffinity chromatography, microparticle material synthesis and biosensing, in the diagnosis and diagnosis of parasitic pathogens. The progress of new nano-insect repellent drug lipid carrier, chemical synthesis medicine and herbal medicine research and development had been discussed here, in addition to liposomes, polymer particles, and cytokines in vaccine adjuvants. This review could be expected as a reference for nanotechnology in in-depth research and better application in parasitology.

Key words: nanotechnology; parasitology; nano-gold labeling; drug carrier; vaccine adjuvant

CLC Number:

S852.71

CHANG Jiang-yan, LI Zhao, FEI Shao-jiang, YANG Jian-fa, ZOU Feng-cai. Application of Nanotechnology in Parasitology[J]. , 2017, 44(11): 3294-3299.

References

[1] Hulla J E,Sahu S C,Hayes A W.Nanotechnology:History and future[J].Hum Exp Toxicol, 2015,3(12):1318-1321.
[2] 周岩,许学年,姚恺龄, 等. 华支睾吸虫PPMPⅠ型抗原重组Cs2蛋白免疫诊断价值的评价[J]. 中国寄生虫学与寄生虫病杂志,2011,29(3):172-176.
[3] Fu B Q, Li W H, Gai W Y,et al. Detection of anti-trichinella antibodies in serum of experimentally infected swine by immunochromatographic strip[J].Vet Parasitol, 2013,194(2-4):125-127.
[4] 王秋霞. 亚洲型猪囊尾蚴3个低分子量抗原基因的克隆、表达及ELISA检测方法的建立[D].郑州:河南农业大学, 2009.
[5] 郭艳红. 家畜日本血吸虫病诊断试纸条研制及望江县放牧牛蠕虫感染状况调查[D].北京:中国农业科学院, 2014.
[6] 许瑞,赵登云,陆珂, 等. 诊断家畜日本血吸虫感染胶体金免疫层析试纸条的研制[J].中国血吸虫病防治杂志, 2015,27(5):474-478.
[7] 许瑞. 诊断家畜日本血吸虫病胶体金免疫层析试纸条的研制[D].北京:中国农业科学院, 2016.
[8] Wang Y, Wang L, Zhang J, et al. Preparation of colloidal gold immunochromatographic strip for detection of Paragonimiasis skrjabini[J]. PLoS One, 2014,9(3):e92034.
[9] 王华俊, 刘宇, 蒋薇, 等. 大片形吸虫免疫胶体金检测试纸条的研制及初步应用[J]. 中国畜牧兽医,2017,44(1):254-261.
[10] Corstjens P L, de Dood C J, Priest J W, et al. Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer[J]. PLoS Negl Trop Dis, 2014,8(7):e2944.
[11] Hegazy S, Farid A, Rabae I, et al. Novel IMB-ELISA assay for rapid diagnosis of human toxoplasmosis using SAG1 antigen[J]. Jpn J Infect Dis, 2015,68(6):474-480.
[12] Jiang W, Liu Y, Chen Y, et al. A novel dynamic flow immunochromatographic test (DFICT) using gold nanoparticles for the serological detection of Toxoplasma gondii infection in dogs and cats[J]. Biosens Bioelectron, 2015,72:133-139.
[13] Zeng S, Tian Z, Che H, et al. Novel printed electrode immunosensors for Schistosoma japonicum[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2012,37(6):541-548.
[14] Toubanaki D K, Athanasiou E, Karagouni E. Gold nanoparticle-based lateral flow biosensor for rapid visual detection of Leishmania-specific DNA amplification products[J]. J Microbiol Methods, 2016,127:51-58.
[15] Jain S A, Basu H, Prabhu P S, et al. Parasite impairment by targeting plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers[J]. Biomaterials, 2014,35(24):6636-6645.
[16] Ali Z, Mishra N, Baldi A. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria[J]. Artif Cells Nanomed Biotechnol, 2016,44(2):545-549.
[17] Prabhu P, Suryavanshi S, Pathak S, et al. Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy:Enhanced efficacy at reduced dose and dosing frequency[J]. Int J Pharm, 2016,511(1):473-487.
[18] Prabhu P, Suryavanshi S, Pathak S,et al. Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria[J]. Int J Pharm, 2016,513(1-2):504-517.
[19] 张学农. 阿苯达唑口服纳米球的制备及其组织靶向性研究[D].乌鲁木齐:新疆医科大学, 2001.
[20] 王艳玲. 伊维菌素药物输送载体[D].青岛:中国海洋大学, 2009.
[21] 张晓东. 伊维菌素-二氧化硅纳米缓释颗粒的制备及羊血浆中伊维菌素测定方法的建立[D].郑州:河南农业大学, 2013.
[22] 张晓燕. 复方吡喹酮纳米乳的制备[D].杨凌:西北农林科技大学, 2012.
[23] 陈纭. 苦参素缓释纳米球的研制及其在大鼠体内的药代动力学和靶向性研究[D].合肥:安徽医科大学, 2009.
[24] 袁苗苗. 抗包虫药物的筛选及植入式医疗器械电源系统的研究[D].兰州:兰州大学, 2016.
[25] Qu D, Han J, Du A. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re[J]. Exp Parasitol, 2013,135(2):234-239.
[26] 许利耕, 陈春英. 纳米材料作为重大疾病疫苗载体或佐剂的研究进展[J]. 科学通报, 2012(25):2341-2353.
[27] Santos L E, Colhone M C, Daghastanli K R, et al. Lipid microspheres loaded with antigenic membrane proteins of the Leishmania amazonensis as a potential biotechnology application[J]. J Colloid Interface Sci, 2009,340(1):112-118.
[28] Heravi S V, Jaafari M R, Khamesipour A, et al. Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis[J]. Parasitol Res, 2012,111(1):105-114.
[29] Golali E, Jaafari M R, Khamesipour A, et al. Comparison of in vivo adjuvanticity of liposomal PO CpG ODN with liposomal PS CpG ODN:Soluble Leishmania antigens as a model[J]. Iran J Basic Med Sci, 2012,15(5):1032-1045.
[30] Firouzmand H, Badiee A, Khamesipour A, et al. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing s-oluble Leishmania antigen (SLA)[J]. Acta Trop, 2013,128(3):528-535.
[31] Tafaghodi M, Eskandari M, Kharazizadeh M, et al. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins[J]. Trop Biomed, 2010,27(3):639-650.
[32] Santos D M, Carneiro M W, de Moura T R, et al. Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11[J]. Int J Nanomedicine, 2012,7:2115-2127.
[33] 陈留林. AL/CS/DNA与OVA/PLGA/GC纳米载体用于鼻腔粘膜免疫的研究[D].武汉:华中科技大学, 2013.
[34] Zarrati S, Mahdavi M, Tabatabaie F.Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major[J]. J Parasit Dis, 2016,40(2):427-435.
[35] Tewary P, Saxena S, Madhubala R. Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis[J]. Vaccine, 2006,24(13):2409-2416.
[36] 张蕾. 抗日本血吸虫感染表位PDDV疫苗的研究[D].南京:南京医科大学, 2007.
[37] Lee M S, Igari Y, Tsukui T, et al. Current status of synthetic hemozoin adjuvant:A preliminary safety evaluation[J]. Vaccine, 2016,34(18):2055-2061.
[38] Zhao Y, Huang B, Huang S, et al. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models[J]. Parasitol Res, 2013,112(9):3151-3160.
[39] 姚媛. 抗日本血吸虫硫氧还蛋白谷胱甘肽还原酶(Sj TGR)纳米抗体的制备与功能分析[D].无锡:江苏省血吸虫病防治研究所, 2014.
[40] 尹青. 弓形虫Δbag1Δku80株的构建及其作为猫弓形虫病疫苗候选株的免疫原性、安全性和效力的评价[D].北京:中国农业大学, 2015.
[41] 吕晓蓉, 李超, 王东亮, 等. 纳米药物研究国际发展态势——基于SCI论文的统计分析纳米药物研究国际发展态势[J]. 科学观察, 2013,3:53-57.
[42] Mukhopadhyay S S. Nanotechnology in agriculture:Prospects and constraints[J]. Nanotechnol Sci Appl, 2014,7:63-71.

Application of Nanotechnology in Parasitology

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments

[1]	HAN Bing, TANG Siqi, ZHU Dawei, LI Hailing, FENG Yali, SU Chaofan, XU Yina, LENG Haoyu, WANG Yongtao, ZHANG Yuemei, TAI Xiaochun, ZHANG Ying. Research Progress of Novel Vaccine Adjuvants [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(6): 2460-2467.
[2]	YANG Jinxin, WANG Haijun, ZHAO Yongkun, PEI Zhihua, SUN Mingjie, WANG Kai, HU Guixue. Research Progress on Exosome Function and Its Clinical Application [J]. , 2018, 45(12): 3608-3613.
[3]	WANG Ru;XIE Yinqian;SHEN Zhiqiang;MIAO Xiaoqing . The Immunological Enhancement and Application of Propolis [J]. , 2007, 34(2): 93-95.